PrimeC — NDA/BLA submission
Dec 2026
Health Canada New Drug Submission for PrimeC in ALS: targeted for December 2026.Source filing
catalyst calendar
NEUROSENSE THERAPEUTICS LTD · Data as of 2026-10-27
Dec 2026
Health Canada New Drug Submission for PrimeC in ALS: targeted for December 2026.Source filing